SCHEMBL22097185

SCHEMBL22097185

C1=Cc2nc(-c3ccc4c(c3)c3ccccc3c3cc5c(cc43)oc3ccccc35)nc(-c3ccccc3)c2CC1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.32
▸ AHR P35869 2/20 0.32
▸ CHEK2 O96017 1/20 0.31
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ATM Q13315 1/20 0.30
▸ HTR2A P28223 1/20 0.30
▸ HTR2C P28335 1/20 0.30
▸ HTR2B P41595 1/20 0.30
▸ MAOA P21397 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ PDGFRB P09619 1/20 0.30
▸ KIT P10721 1/20 0.30
▸ FLT3 P36888 1/20 0.30
▸ HDAC6 Q9UBN7 1/20 0.30
▸ TTR P02766 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097184 0.79 MEN1 (0.51) AHRCHEK2MEN1KMT2AMAPT
SCHEMBL22097036 0.78 AHR (0.44) AHRCHEK2MEN1KMT2AMAPT
SCHEMBL22097211 0.78 AHR (0.44) AHRCHEK2MEN1KMT2AMAPT
SCHEMBL18698090 0.78 HTR2A (0.41) MEN1KMT2AMAPTALDH1A1ATM
SCHEMBL22097252 0.77 AHR (0.42) MMP12AHRCHEK2MEN1KMT2A
SCHEMBL22097256 0.77 AHR (0.42) MMP12AHRCHEK2MEN1KMT2A
SCHEMBL22097194 0.76 MEN1 (0.44) AHRCHEK2MEN1KMT2AMAPT
SCHEMBL24686498 0.76 PLA2G2A (0.35) MMP12AHRCHEK2MEN1KMT2A
SCHEMBL26019717 0.76 KMT2A (0.36) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL22096949 0.75 CYP1A1 (0.38) AHRCHEK2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 — — US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 MMP12 3878/4885AHR 1872/4885CHEK2 4749/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MMP12 3878/4885AHR 1872/4885CHEK2 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback